49 related articles for article (PubMed ID: 16831859)
1. A high-throughput drug screening system for HIV-1 transcription inhibitors.
Kempf MC; Jones J; Heil ML; Kutsch O
J Biomol Screen; 2006 Oct; 11(7):807-15. PubMed ID: 16831859
[TBL] [Abstract][Full Text] [Related]
2. A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors.
Daelemans D; Pannecouque C; Pavlakis GN; Tabarrini O; De Clercq E
Mol Pharmacol; 2005 May; 67(5):1574-80. PubMed ID: 15728798
[TBL] [Abstract][Full Text] [Related]
3. High-throughput screening using pseudotyped lentiviral particles: a strategy for the identification of HIV-1 inhibitors in a cell-based assay.
Garcia JM; Gao A; He PL; Choi J; Tang W; Bruzzone R; Schwartz O; Naya H; Nan FJ; Li J; Altmeyer R; Zuo JP
Antiviral Res; 2009 Mar; 81(3):239-47. PubMed ID: 19118579
[TBL] [Abstract][Full Text] [Related]
4. T-cell line for HIV drug screening using EGFP as a quantitative marker of HIV-1 replication.
Ochsenbauer-Jambor C; Jones J; Heil M; Zammit KP; Kutsch O
Biotechniques; 2006 Jan; 40(1):91-100. PubMed ID: 16454046
[TBL] [Abstract][Full Text] [Related]
5. Identification by high throughput screening of small compounds inhibiting the nucleic acid destabilization activity of the HIV-1 nucleocapsid protein.
Shvadchak V; Sanglier S; Rocle S; Villa P; Haiech J; Hibert M; Van Dorsselaer A; Mély Y; de Rocquigny H
Biochimie; 2009 Jul; 91(7):916-23. PubMed ID: 19401213
[TBL] [Abstract][Full Text] [Related]
6. New alkenyldiarylmethanes with enhanced potencies as anti-HIV agents which act as non-nucleoside reverse transcriptase inhibitors.
Cushman M; Casimiro-Garcia A; Hejchman E; Ruell JA; Huang M; Schaeffer CA; Williamson K; Rice WG; Buckheit RW
J Med Chem; 1998 Jun; 41(12):2076-89. PubMed ID: 9622549
[TBL] [Abstract][Full Text] [Related]
7. A fluorescence-based high-throughput screening assay to identify HIV-1 inhibitors.
Geluykens P; Van Acker K; Vingerhoets J; Van den Eynde C; Van Loock M; Dams G
Methods Mol Biol; 2013; 1030():3-9. PubMed ID: 23821255
[TBL] [Abstract][Full Text] [Related]
8. [Screening of HIV-1 replication inhibitors by using pseudotyped virus system].
Cao YL; Guo Y
Yao Xue Xue Bao; 2008 Mar; 43(3):253-8. PubMed ID: 18630260
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.
Bermejo M; Sánchez-Palomino S; Usán L; Alcamí J
J Med Virol; 2004 Aug; 73(4):502-7. PubMed ID: 15221892
[TBL] [Abstract][Full Text] [Related]
11. A novel HIV-1 antiviral high throughput screening approach for the discovery of HIV-1 inhibitors.
Blair WS; Isaacson J; Li X; Cao J; Peng Q; Kong GF; Patick AK
Antiviral Res; 2005 Feb; 65(2):107-16. PubMed ID: 15708637
[TBL] [Abstract][Full Text] [Related]
12. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.
Brown A; Gartner S; Kawano T; Benoit N; Cheng-Mayer C
J Leukoc Biol; 2005 Sep; 78(3):675-85. PubMed ID: 16000390
[TBL] [Abstract][Full Text] [Related]
13. Antiviral effects of mifepristone on human immunodeficiency virus type-1 (HIV-1): targeting Vpr and its cellular partner, the glucocorticoid receptor (GR).
Schafer EA; Venkatachari NJ; Ayyavoo V
Antiviral Res; 2006 Dec; 72(3):224-32. PubMed ID: 16889838
[TBL] [Abstract][Full Text] [Related]
14. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.
Furtado MR; Callaway DS; Phair JP; Kunstman KJ; Stanton JL; Macken CA; Perelson AS; Wolinsky SM
N Engl J Med; 1999 May; 340(21):1614-22. PubMed ID: 10341273
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
16. Enhanced HIV-1 replication in retinoid-treated monocytes. Retinoid effects mediated through mechanisms related to cell differentiation and to a direct transcriptional action on viral gene expression.
Turpin JA; Vargo M; Meltzer MS
J Immunol; 1992 Apr; 148(8):2539-46. PubMed ID: 1560208
[TBL] [Abstract][Full Text] [Related]
17. High throughput drug screening for human immunodeficiency virus type 1 reactivating compounds.
Jones J; Rodgers J; Heil M; May J; White L; Maddry JA; Fletcher TM; Shaw GM; Hartman JL; Kutsch O
Assay Drug Dev Technol; 2007 Apr; 5(2):181-89. PubMed ID: 17477827
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Vpr-induced cell cycle abnormality by quercetin: a novel strategy for searching compounds targeting Vpr.
Shimura M; Zhou Y; Asada Y; Yoshikawa T; Hatake K; Takaku F; Ishizaka Y
Biochem Biophys Res Commun; 1999 Aug; 261(2):308-16. PubMed ID: 10425183
[TBL] [Abstract][Full Text] [Related]
19. Altered replication of human immunodeficiency virus type 1 (HIV-1) in T cell lines retrovirally transduced to express Herpesvirus saimiri proteins StpC and/or Tip.
Henderson EE; Tsygankov AY; Merlo JJ; Romano G; Guan M
Virology; 1999 Nov; 264(1):125-33. PubMed ID: 10544137
[TBL] [Abstract][Full Text] [Related]
20. The novel histone deacetylase inhibitors metacept-1 and metacept-3 potently increase HIV-1 transcription in latently infected cells.
Shehu-Xhilaga M; Rhodes D; Wightman F; Liu HB; Solomon A; Saleh S; Dear AE; Cameron PU; Lewin SR
AIDS; 2009 Sep; 23(15):2047-50. PubMed ID: 19609198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]